GAD1 and type 1 diabetes mellitus: Further evaluation revealed serum C-peptide at <0.03 ng/mL and anti-glutamic acid decarboxylase (GAD) antibody at <5.0 U/mL, leading to a diagnosis of fulminant type 1 diabetes.